MedTrace Logo

The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) Values

NCT05438524 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2024-11-22

No results posted yet for this study

Summary

This study is to investigate, in a larger cohort of consecutive men, the proportion of abnormal MRI prostate in different phi ranges, and the cancer detected in Chinese men with abnormal MRI. This study aims to evaluate whether MRI prostate can be omitted in men with lower suspicion of prostate cancer.

Conditions

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Peter Ka-Fung CHIU, FRCS, PhD · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-11
Primary Completion
2023-12-27
Completion
2024-02-01

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438524 on ClinicalTrials.gov